Interactions between capillary function, inflammation, hypoxia, and neurotransmission. The expression of ACE2 and other SARS‐CoV‐2 entry factors on parenchymal cells and observations of infected cells in biopsy material hold important clues to understand COVID‐19‐related organ damage. COVID-19 Blood Vessel Damage May Cause Brain Fog and Other Long-hauler Symptoms

Interactions between capillary function, inflammation, hypoxia, and neurotransmission. The expression of ACE2 and other SARS‐CoV‐2 entry factors on parenchymal cells and observations of infected cells in biopsy material hold important clues to understand COVID‐19‐related organ damage. Find more figures and read the full study.

News | Coronavirus (COVID-19) | March 12, 2021
March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a...
Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman. Hopes to build the Cordis Accelerator for innovative cardiovascular device development.
News | Cardiovascular Business | March 12, 2021
March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to...
An example of intra-cardiac echo (ICE) imaging from Siemens Healthineers showing color flow Doppler with severe valve regurgitation. ICE has seen wider use in transcatheter structural heart  procedures because, unlike TEE, it can be used without deeper sedation of anesthesia.

An example of intra-cardiac echo (ICE) imaging from Siemens Healthineers showing color flow Doppler with severe valve regurgitation. ICE has seen wider use in transcatheter structural heart procedures because, unlike TEE, it can be used without deeper sedation of anesthesia.

Feature | Ultrasound Intra-cardiac Echo (ICE) | March 11, 2021 | By Dave Fornell, Editor
Intra-cardiac Echocardiography (ICE) uses catheter-based cardiac ultrasound array to image anatomy and devices inside...
The Teleflex Manta large-bore vascular closure device can seal holes between 12 and 25 French.

The Teleflex Manta large-bore vascular closure device can seal holes between 12 and 25 French. 

Feature | Hemostasis Management | March 09, 2021 | Dave Fornell, Editor
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these...
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a...
AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021
Feature | ACC | March 08, 2021 | Dave Fornell, Editor
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced...
CardioBra is a two-part system, uniquely designed to work with Claravue electrodes by Nissha Medical Technologies. CardioBra used with Claravue reinforces electrode adherence and promotes ECG lead placement under the breast with added support. Claravue's low-profile pre-wired design eliminates the pinch clips allowing for a comfortable fit. Womens heart health. Female stress testing.

The CardioBra is a two-part system, designed to work with Claravue electrodes by Nissha Medical Technologies. It reinforces electrode adherence and promotes ECG lead placement under the breast with added support. Claravue's low-profile pre-wired design eliminates the pinch clips allowing for a comfortable fit.

News | Womens Cardiovascular Health | March 08, 2021
March 8, 2021 — University of Kansas Health System Cardiologist Ashley Simmons, M.D., knew there could and should be a...
News | Cardiac Resynchronization Therapy Devices (CRT) | March 03, 2021
March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac...
Impulse Dynamics Optimizer Smart device is an implantable device that helps optimize cardiac pumping action in heart failure patients.

Impulse Dynamics Optimizer Smart device is an implantable device that helps optimize cardiac pumping action in heart failure patients.

News | Heart Failure | March 03, 2021
March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization,...
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management...
News | Atrial Fibrillation | March 03, 2021
March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S. Food and Drug...
LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center. 

LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center. 

News | Heart Failure | March 02, 2021
March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant...
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries
News | Ventricular Assist Devices (VAD) | March 01, 2021
March 1, 2021 — Medtronic is recalling the HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit because the left...
The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.

The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.

Feature | March 01, 2021
March 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
FDA Clears Third COVID-19 Vaccine From Janssen, Johnson and Johnson, J&J
News | Coronavirus (COVID-19) | March 01, 2021
March 1, 2021 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the third...